Literature DB >> 25150291

Novel DYT11 gene mutation in patients without dopaminergic deficit (SWEDD) screened for dystonia.

Roberto Cilia1, Chiara Reale2, Anna Castagna2, Alessia Nasca2, Marco Muzi-Falconi2, Chiara Barzaghi2, Alberto Marzegan2, Magda Granata2, Giorgio Marotta2, Giorgio Sacilotto2, Davide Vallauri2, Gianni Pezzoli2, Stefano Goldwurm2, Barbara Garavaglia2.   

Abstract

OBJECTIVE: To test the hypothesis that adult-onset primary dystonia may be the underlying etiology of tremulous patients with clinical diagnosis of Parkinson disease (PD) but without evidence of dopaminergic deficit at nigrostriatal SPECT imaging.
METHODS: We retrospectively reviewed clinical and imaging data of patients with clinical diagnosis of PD assessed at our tertiary movement disorder clinic, who underwent dopamine transporter SPECT imaging consecutively between 2002 and 2011. Molecular screening for DYT1, DYT5, DYT6, DYT11, and DYT16 dystonia genes was performed in all cases who met the following criteria at the time of SPECT scan: (1) clinical diagnosis of PD; (2) normal dopamine transporter SPECT; (3) asymmetric rest tremor, with or without postural/kinetic component; (4) ≥ 12-month follow-up; and (5) normal brain MRI. We excluded subjects with (6) overt dystonic features, and (7) head or voice tremor.
RESULTS: Twenty-three subjects were eligible for molecular analysis. Positive family history for tremor or PD was present in 45% of probands. We found one patient with a novel heterozygous frameshift mutation in the DYT11 gene (c.1058-1062 delCACCA/p.Gln352fsX376). Electrophysiologic study of tremor revealed that the main contributor was 5- to 6-Hz pseudo-rhythmic myoclonus, primarily involving extensor muscles. In 2 brothers, we found a missense variant in the DYT5 gene (c.334A>G; p.Thr112Ala) of uncertain pathogenicity in humans.
CONCLUSION: Our findings provide further support to the hypothesis that adult-onset monogenic dystonia may underlie a "PD look-alike" clinical phenotype. In addition to dystonic tremor, pseudo-rhythmic myoclonus may be mischaracterized as "rest tremor."
© 2014 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25150291     DOI: 10.1212/WNL.0000000000000821

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

Review 1.  Rest tremor in dystonia: epidemiology, differential diagnosis, and pathophysiology.

Authors:  Navnika Gupta; Sanjay Pandey
Journal:  Neurol Sci       Date:  2020-04-23       Impact factor: 3.307

2.  Parkinsonism in GTP cyclohydrolase 1-deficient DOPA-responsive dystonia.

Authors:  Yoshiaki Furukawa; Stephen J Kish
Journal:  Brain       Date:  2014-11-21       Impact factor: 13.501

Review 3.  Dopa-responsive dystonia--clinical and genetic heterogeneity.

Authors:  Subhashie Wijemanne; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2015-06-23       Impact factor: 42.937

Review 4.  Unexpected (123I)FP-CIT SPECT findings: SWIDD, SWEDD and all DAT.

Authors:  Balestrino Roberta; Barone Paolo; Filippi Massimo; Erro Roberto
Journal:  J Neurol       Date:  2021-09-18       Impact factor: 6.682

5.  Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition Cohort.

Authors:  Aasef G Shaikh; Sinem Balta Beylergil; Laura Scorr; Gamze Kilic-Berkmen; Alan Freeman; Christine Klein; Johanna Junker; Sebastian Loens; Norbert Brüggemann; Alexander Münchau; Tobias Bäumer; Marie Vidailhet; Emmanuel Roze; Cecilia Bonnet; Joseph Jankovic; Joohi Jimenez-Shahed; Neepa Patel; Laura Marsh; Cynthia Comella; Richard L Barbano; Brian D Berman; Irene Malaty; Aparna Wagle Shukla; Stephen G Reich; Mark S Ledoux; Alfredo Berardelli; Gina Ferrazzano; Natividad Stover; William Ondo; Sarah Pirio Richardson; Rachel Saunders-Pullman; Zoltan Mari; Pinky Agarwal; Charles Adler; Sylvain Chouinard; Susan H Fox; Allison Brashear; Daniel Truong; Oksana Suchowersky; Samuel Frank; Stewart Factor; Joel Perlmutter; Hyder Azad Jinnah
Journal:  Neurology       Date:  2020-10-12       Impact factor: 9.910

6.  Familial aggregation of Parkinson's disease and coaggregation with neuropsychiatric diseases: a population-based cohort study.

Authors:  Fu-Chao Liu; Huan-Tang Lin; Chang-Fu Kuo; Mei-Yun Hsieh; Lai-Chu See; Huang-Ping Yu
Journal:  Clin Epidemiol       Date:  2018-05-30       Impact factor: 4.790

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.